Huatai Zijin Investment appeared to be the VC, which was created in 1991. The leading representative office of defined VC is situated in the Nanjing. The company was established in Asia in China.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Huatai Zijin Investment, startups are often financed by IDG Capital, Zero2IPO Ventures, Militello Capital. The meaningful sponsors for the fund in investment in the same round are Highlight Capital, ETP Ventures, Broadhi Capital. In the next rounds fund is usually obtained by Zero2IPO Ventures, Legend Capital, CITIC Securities.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.
Among the most popular portfolio startups of the fund, we may highlight Xiaoi Robot. Among the most popular fund investment industries, there are Hospital, Dental. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
Related Funds
Fund Name | Location |
Aipai | China, Guangdong, Guangzhou |
Brener International Group | Beverly Hills, California, United States |
Capitana Venture Partners | Community of Madrid, Madrid, Spain |
CG Partners | Stockholm, Stockholm County, Sweden |
China Value | - |
Cormorant Global Healthcare Master Fund | - |
Double Sharp Partners | Japan, Minato |
Excubator | Bangalore, India, Karnataka |
Hutchison Group | England, Fenland, United Kingdom |
Karlin Ventures | California, Los Angeles, United States |
NSV Wolf Capital | California, Menlo Park, United States |
Orrick Venture Fund | California, San Francisco, United States |
Soda Rock Partners | - |
TOLMOLBOL.COM PRIVATE LIMITED | - |
Toyota Mobility Foundation | Japan, Tokyo |
TRIBUS | Missouri, Saint Louis, United States |
UCloud Information Technology | China, Shanghai |
Will Group | Chiyoda, Japan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Zhiren Jingxing | $15M | 26 Jan 2024 | Nanjing, Jiangsu, China | ||
Zinsight | 13 Sep 2023 | Minhang, Shanghai, China | |||
Zigge Technology | $15M | 24 Jul 2023 | Haidian, Beijing, China | ||
Hengyu Medical | $15M | 18 Jul 2023 | Guangdong, Tianjin, China | ||
Eaglenos | $23M | 29 May 2023 | Nanjing, Jiangsu, China | ||
Primont | $30M | 24 Apr 2023 | Nanjing, Jiangsu, China | ||
Tingsheng Technology | $15M | 29 Jan 2023 | Nanjing, Jiangsu, China | ||
GenScript ProBio | $220M | 18 Jan 2023 | Nanjing, Jiangsu, China | ||
Proton Bio | $80M | 19 Aug 2022 | Suzhou, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Zhiren Jingxing | $15M | 26 Jan 2024 | Nanjing, Jiangsu, China | ||
Zinsight | 13 Sep 2023 | Minhang, Shanghai, China | |||
Zigge Technology | $15M | 24 Jul 2023 | Haidian, Beijing, China | ||
Hengyu Medical | $15M | 18 Jul 2023 | Guangdong, Tianjin, China | ||
Eaglenos | $23M | 29 May 2023 | Nanjing, Jiangsu, China | ||
Primont | $30M | 24 Apr 2023 | Nanjing, Jiangsu, China | ||
Tingsheng Technology | $15M | 29 Jan 2023 | Nanjing, Jiangsu, China | ||
GenScript ProBio | $220M | 18 Jan 2023 | Nanjing, Jiangsu, China | ||
Proton Bio | $80M | 19 Aug 2022 | Suzhou, Jiangsu, China |